Dynavax Technologies Co. Sees Large Decline in Short Interest - MarketBeat
DVAX Stock | USD 9.78 0.02 0.20% |
Slightly above 61% of Dynavax Technologies' investor base is looking to short. The analysis of the overall investor sentiment regarding Dynavax Technologies suggests that many traders are alarmed. Dynavax Technologies' investing sentiment can be driven by a variety of factors including economic data, Dynavax Technologies' earnings reports, geopolitical events, and overall market trends.
Dynavax Technologies Co. Sees Large Decline in Short Interest MarketBeat
Read at news.google.com
![]() |
Dynavax Technologies Maximum Pain Price Across July 18th 2025 Option Contracts
Dynavax Technologies' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Dynavax Technologies close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Dynavax Technologies' options.
Dynavax Technologies Fundamental Analysis
We analyze Dynavax Technologies' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dynavax Technologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dynavax Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
Dynavax Technologies is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Dynavax Technologies Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dynavax Technologies stock to make a market-neutral strategy. Peer analysis of Dynavax Technologies could also be used in its relative valuation, which is a method of valuing Dynavax Technologies by comparing valuation metrics with similar companies.
Peers
Dynavax Technologies Related Equities
IRWD | Ironwood Pharmaceuticals | 8.77 | ||||
AQST | Aquestive Therapeutics | 8.51 | ||||
LNTH | Lantheus Holdings | 2.57 | ||||
COLL | Collegium Pharmaceutical | 2.15 | ||||
NBIX | Neurocrine Biosciences | 2.05 | ||||
ALKS | Alkermes Plc | 1.87 | ||||
ANIP | ANI Pharmaceuticals | 0.92 | ||||
PCRX | Pacira BioSciences, | 0.27 | ||||
AMPH | Amphastar | 0.86 | ||||
EBS | Emergent Biosolutions | 1.54 | ||||
DRRX | Durect | 7.41 |
Additional Tools for Dynavax Stock Analysis
When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.